Related Experiment Videos
(1-->3)-beta-D-glucan may contribute to pollen sensitivity
R Rylander1, B Fogelmark, A McWilliam
1Department of Environmental Medicine, Gothenburg University, Sweden. ragnar.rylander@envmed.gu.se
Clinical and Experimental Immunology
|April 8, 1999
Summary
Pollen contains (1-->3)-beta-D-glucan, a compound that can trigger airway inflammation. Inhaled doses during high pollen seasons may exceed harmful levels, posing a respiratory health risk.
Area of Science:
- Environmental Science
- Immunology
- Biochemistry
Background:
- Airborne pollen is a common allergen.
- Pollen contains various bioactive compounds, including (1-->3)-beta-D-glucan.
- Beta-glucans are known to activate immune responses.
Purpose of the Study:
- To quantify (1-->3)-beta-D-glucan levels in pollen from diverse plant species.
- To assess the potential respiratory health risks associated with inhaled pollen beta-glucans.
Main Methods:
- Utilized the Limulus assay with a specific lysate for accurate (1-->3)-beta-D-glucan detection.
- Collected and analyzed pollen samples from various botanical sources.
- Calculated potential inhaled doses based on environmental pollen concentrations.
Main Results:
- Quantified (1-->3)-beta-D-glucan content, ranging from 79 to 1800 ng/10(6) pollen.
- Determined that inhaled doses during high pollen periods can surpass levels known to induce airway inflammation.
- Identified significant variability in beta-glucan content across different plant pollens.
Conclusions:
- Airborne pollen contributes to inhaled (1-->3)-beta-D-glucan exposure.
- Elevated pollen beta-glucan levels during peak seasons may exacerbate respiratory conditions.
- Further research is warranted to understand the full clinical impact of pollen-derived beta-glucans.